Mutational context and diverse clonal development in early and late bladder cancer.
暂无分享,去创建一个
T. Ørntoft | J. S. Pedersen | K. Birkenkamp-Demtröder | S. Shah | H. Hornshøj | Malene Juul | Andrew Roth | J. Hedegaard | P. Villesen | K. Thorsen | M. Borre | L. Dyrskjøt | K. Shumansky | I. Nordentoft | P. Lamy | S. Høyer | S. Vang | T. Reinert | N. Fristrup | Søren Vang | Sohrab P. Shah | Niels Fristrup | Kasper Thorsen
[1] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[2] Kai Wang,et al. Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy , 2014, Modern Pathology.
[3] Jason B. Nikas,et al. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. , 2013, Cancer research.
[4] Huanming Yang,et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation , 2013, Nature Genetics.
[5] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[6] A. Valencia,et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy , 2013, Nature Genetics.
[7] M. Babjuk,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. , 2013, European urology.
[8] C. Sander,et al. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Steven A. Roberts,et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.
[10] N. A. Temiz,et al. Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.
[11] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[12] M. Kotler,et al. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. , 2013, Cancer research.
[13] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[14] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[15] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[16] Carlos Caldas,et al. The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.
[17] N. A. Temiz,et al. APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.
[18] Per-Uno Malmström,et al. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer. , 2013, The American journal of pathology.
[19] S. Gabriel,et al. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability , 2012, Genome research.
[20] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[21] I. Willner,et al. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. , 2012, Blood.
[22] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[23] A. Bashashati,et al. Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer , 2012, Genome research.
[24] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[25] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[26] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[27] Albert J. Vilella,et al. Insights into hominid evolution from the gorilla genome sequence , 2012, Nature.
[28] Huanming Yang,et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder , 2011, Nature Genetics.
[29] Michael C. Rusch,et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.
[30] Carsten Wiuf,et al. Rseg - an R package to optimize segmentation of SNP array data , 2011, Bioinform..
[31] J. Hoeijmakers,et al. Involvement of Global Genome Repair, Transcription Coupled Repair, and Chromatin Remodeling in UV DNA Damage Response Changes during Development , 2010, PLoS genetics.
[32] K. Baggerly,et al. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy , 2008, Laboratory Investigation.
[33] H. Abol‐enein. Infection: Is it a cause of bladder cancer? , 2008, Scandinavian journal of urology and nephrology. Supplementum.
[34] Ziheng Yang. PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.
[35] Mogens Kruhøffer,et al. Gene Expression in the Urinary Bladder , 2004, Cancer Research.
[36] P. Green,et al. Transcription-associated mutational asymmetry in mammalian evolution , 2003, Nature Genetics.
[37] Torben F. Ørntoft,et al. Identifying distinct classes of bladder carcinoma using microarrays , 2003, Nature Genetics.
[38] T. H. van der Kwast,et al. Molecular evolution of multiple recurrent cancers of the bladder. , 2000, Human molecular genetics.